| Literature DB >> 28350963 |
Xiao-Yu Zheng1, Kai Zhao2, Jinglong Tang3, Xin-Yu Wang1, Lin-Dong Li1, Nai-Xiu Chen1, Yan-Jie Wang1, Shuo Shi1, Xiaodong Zhang2, Sivakumar Malaisamy1, Ling-Dong Sun1, Xiaoying Wang2, Chunying Chen3, Chun-Hua Yan1.
Abstract
Magnetic resonance imaging contrast agents with both significantly enhanced relaxivity and minimal safety risk are of great importance for sensitive clinical diagnosis, but have rarely been reported. Herein, we present a simple strategy to improve relaxivity by introducing surface ligands with strong interaction to water molecules. As a proof of concept, NaGdF4 nanoparticles (NPs) capped by poly(acrylic acid) (PAA) show superior relaxivity to those capped by polyethylenimine and polyethylene glycol, which is attributed to the strong hydrogen-bond capacity of PAA to water molecules as revealed by theoretical calculation. Furthermore, benefiting from PAA and ultrasmall particle size, Gd-dots, namely PAA-capped GdOF NPs (2.1 ± 0.2 nm), are developed as a high-performance contrast agent, with a remarkable ionic relaxivity of ∼75 mM-1 s-1 in albumin solution at 0.5 T. These Gd-dots also exhibit efficient renal clearance with <3% of injected amount left 12 h post-injection. Ultrasensitive MR renography achieved with Gd-dots strongly suggests their great potential for practical applications.Entities:
Keywords: contrast agents; ligand effects; magnetic resonance imaging; nanoparticles; rare earths
Year: 2017 PMID: 28350963 DOI: 10.1021/acsnano.6b07959
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881